Dopamine suppresses pituitary function in infants and children

Area of Science:

• Pediatric Intensive Care Medicine
• Endocrinology
• Pharmacology

Background:

• Dopamine is a critical inotropic and vasoactive agent in pediatric intensive care.
• The pituitary gland is vital for growth, metabolism, and maturation in children.
• The effects of dopamine on pituitary-thyroid axis in critically ill children are not fully understood.

Purpose of the Study:

• To evaluate the impact of dopamine infusion on prolactin, growth hormone, and thyrotropin secretion.
• To assess dopamine's effect on the thyroid axis in critically ill infants and children.
• To investigate hormone dynamics following dopamine withdrawal.

Main Methods:

• Prospective, randomized, controlled, open-label clinical study.
• Critically ill infants and children recovering from cardiovascular surgery were studied.
• Hormone levels (prolactin, GH, IGF-1, TSH, T4, T3, reverse T3) were measured dynamically before and after dopamine withdrawal.

Main Results:

• Dopamine suppressed prolactin, growth hormone, and thyrotropin in newborns, with rebound after withdrawal.
• In children, dopamine suppressed prolactin and thyrotropin, but not growth hormone, with rebound effects.
• Thyroid hormone levels (T3, T4) and T3/reverse T3 ratio were altered, suggesting euthyroid sick syndrome, particularly in children.

Conclusions:

• Dopamine infusion may induce or worsen partial hypopituitarism in critically ill infants and children.
• Dopamine administration is associated with the development or exacerbation of euthyroid sick syndrome.
• These findings highlight potential endocrine complications of dopamine therapy in pediatric critical care.